Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.

Dev, Harveer, Linch, Mark, Narahari, Krishna, Milne-Clark, Toby, Cheung, Melissa, Warren, Anne, Malaviya, Alopa, Gnanapragasam, Vincent, Hernandez, Tatiana, Bullock, Nicholas, Machin, Andrea, Dayimu, Alimu, Robb, Tamsin, Cromwell, Elizabeth, Freeman, Alex, Harrington, Elizabeth A, Camacho, Niedzika, Glont, Silvia, Squatrito, Massimo, Rotem, Asaf, Moore, Luiza, Hanson, Robert, Dodd, Marc, Anand, Shubha, Kynaston, Howard, Shaw, Greg, Shah, Nimish, Pacey, Simon

Open source

DOI
10.17863/cam.117901
Published
2025
Container
Not recorded
Publisher
American Association for Cancer Research (AACR)
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17863/cam.117901,
  title = {Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.},
  author = {Dev, Harveer and Linch, Mark and Narahari, Krishna and Milne-Clark, Toby and Cheung, Melissa and Warren, Anne and Malaviya, Alopa and Gnanapragasam, Vincent and Hernandez, Tatiana and Bullock, Nicholas and Machin, Andrea and Dayimu, Alimu and Robb, Tamsin and Cromwell, Elizabeth and Freeman, Alex and Harrington, Elizabeth A and Camacho, Niedzika and Glont, Silvia and Squatrito, Massimo and Rotem, Asaf and Moore, Luiza and Hanson, Robert and Dodd, Marc and Anand, Shubha and Kynaston, Howard and Shaw, Greg and Shah, Nimish and Pacey, Simon},
  year = {2025},
  doi = {10.17863/cam.117901},
  url = {https://doi.org/10.17863/cam.117901}
}

RIS

TY  - JOUR
TI  - Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.
AU  - Dev, Harveer
AU  - Linch, Mark
AU  - Narahari, Krishna
AU  - Milne-Clark, Toby
AU  - Cheung, Melissa
AU  - Warren, Anne
AU  - Malaviya, Alopa
AU  - Gnanapragasam, Vincent
AU  - Hernandez, Tatiana
AU  - Bullock, Nicholas
AU  - Machin, Andrea
AU  - Dayimu, Alimu
AU  - Robb, Tamsin
AU  - Cromwell, Elizabeth
AU  - Freeman, Alex
AU  - Harrington, Elizabeth A
AU  - Camacho, Niedzika
AU  - Glont, Silvia
AU  - Squatrito, Massimo
AU  - Rotem, Asaf
AU  - Moore, Luiza
AU  - Hanson, Robert
AU  - Dodd, Marc
AU  - Anand, Shubha
AU  - Kynaston, Howard
AU  - Shaw, Greg
AU  - Shah, Nimish
AU  - Pacey, Simon
PY  - 2025
DO  - 10.17863/cam.117901
UR  - https://doi.org/10.17863/cam.117901
ER  - 

APA

Harveer, D., Mark, L., Krishna, N., Toby, M., Melissa, C., Anne, W., Alopa, M., Vincent, G., Tatiana, H., Nicholas, B., Andrea, M., Alimu, D., Tamsin, R., Elizabeth, C., Alex, F., A, H. E., Niedzika, C., Silvia, G., Massimo, S., Asaf, R., Luiza, M., Robert, H., Marc, D., Shubha, A., Howard, K., Greg, S., Nimish, S., & Simon, P. (2025). Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.. https://doi.org/10.17863/cam.117901

Source records